Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.490
+0.270 (22.13%)
At close: Nov 20, 2024, 4:00 PM
1.600
+0.110 (7.38%)
Pre-market: Nov 21, 2024, 5:45 AM EST
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $44.09 million as of November 21, 2024. Its market cap has decreased by -9.47% in one year.
Market Cap
44.09M
Enterprise Value
39.54M
1-Year Change
-9.47%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $44.09M, a decrease of -53.49%. That is a compound annual growth rate of -12.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 44.10M | -4.96% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 47.76M |
| Serina Therapeutics | 47.62M |
| CollPlant Biotechnologies | 46.51M |
| Rapid Micro Biosystems | 46.35M |
| SHL Telemedicine | 45.88M |
| CalciMedica | 45.53M |
| Affimed | 44.69M |
| OncoCyte | 44.45M |